Non-vitamin K antagonist oral anticoagulants versus warfarin for cardioversion of atrial fibrillation in clinical practice: A single-center experience
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Arrhythmia"
DOI: 10.1016/j.joa.2016.04.003
Abstract: Anticoagulation therapy with the vitamin K antagonist (VKA) warfarin has been demonstrated to reduce thromboembolic risk after electrical cardioversion (ECV). However, data concerning ECV with non‐VKA oral anticoagulants (NOACs) is limited. The objective of this… read more here.
Keywords: single center; clinical practice; oral anticoagulants; practice single ... See more keywords